Gessel has advised Urteste on the public offering of its new share issuance and switching its market listing from the ASO NewConnect to the regulated market of the Warsaw Stock Exchange.
Dom Maklerski Banku Ochrony Srodowiska coordinating the offering.
Urteste is a biotechnology company from Gdansk that develops a method of detecting cancer from a urine sample.
Gessel’s team included Partner Krzysztof Marczuk, Managing Associate Michal Wielinski, and Associates Dawid Marciniak, Michal Dunikowski, and Piotr Blank.
Gessel did not respond to our inquiry on the matter.
